PIP UNKNOWN XXX-PIP

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-05-17 for PIP UNKNOWN XXX-PIP manufactured by Ascension Orthopedics.

Event Text Entries

[145489979] The device is not expected to be returned to the manufacturer for analysis. The plant investigation is in progress and a supplemental medwatch report will be submitted upon completion of the investigation. Linked to mfg report number: 3003418325-2019-00016.
Patient Sequence No: 1, Text Type: N, H10


[145489980] This is 2 of 2 reports. The journal j hand surg am (2018) published: "medium-term outcomes with pyrocarbon proximal interphalangeal arthroplasty: a study of 170 consecutive arthroplasties. " the purpose of this study was to examine the medium-term outcomes of patients undergoing proximal interphalangeal (pip) joint arthroplasty using a pyrocarbon implant. Methods: the study comprised an analysis of 170 pip joint pyrocarbon arthroplasties in 99 patients with a minimum 2-year clinical follow-up. Diagnoses included inflammatory arthritis, posttraumatic arthritis, and osteoarthritis. Univariate logistic regression and kaplan-meier survival analyses were performed. Results: at an average follow-up of 6 years (range, 2-14 years), 58 reoperations (34%) were required, including 36 (21%) involving implant revision surgery. The majority of revisions were performed for either dislocations (n = 16) or pain and stiffness (n =14). The 5- and 10- year survival-free of revision surgery rates were 79% and 77%, respectively. The risk for revision surgery was higher in patients with posttraumatic arthritis. There were 15 intraoperative complications involving a fracture and 26 postoperative complications, including 21 dislocations. In unrevised implants, patients had significant improvements in their preoperative to postoperative pain levels, with no change in their pip joint total arc of motion. At a mean radiographic follow-up of 5. 4 years, there were 28% with grade 3+ loosening and 36% with progressive implant instability. Implant loosening or progressive instability was not associated with worse pain or pip joint total arc of motion. Conclusions: approximately 1 in 5 pip joint arthroplasties with a pyrocarbon implant will require revision surgery by 5 years, and 1 in 3 will undergo more than 1 operation. Furthermore, 1 in 4 pip joint arthroplasties will have grade 3+ radiographic loosening and 1 in 3 will have progressive loosening or subsidence by 5 years. These results are particularly concerning in young patients and those with posttraumatic arthritis. Overall, in patients that do not require revision surgery, pain relief was improved and motion maintained. Doi. Org/10. 1016/j. Jhsa. 2018. 06. 020. Malfunctions: dislocations (21) - revisions (16); recurrent subluxation with revision (3); implant loosening with revision (2).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3003418325-2019-00017
MDR Report Key8619413
Date Received2019-05-17
Date of Report2019-04-23
Date Mfgr Received2019-06-28
Date Added to Maude2019-05-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactUSER VIVIAN NELSON
Manufacturer Street311 ENTERPRISE DRIVE
Manufacturer CityPLAINSBORO NJ 08536
Manufacturer CountryUS
Manufacturer Postal08536
Manufacturer Phone6099362393
Manufacturer G1ASCENSION ORTHOPEDICS
Manufacturer Street8700 CAMERON ROAD #100
Manufacturer CityAUSTIN TX 78754
Manufacturer CountryUS
Manufacturer Postal Code78754
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NamePIP UNKNOWN
Generic NamePIP
Product CodeNEG
Date Received2019-05-17
Catalog NumberXXX-PIP
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerASCENSION ORTHOPEDICS
Manufacturer Address8700 CAMERON ROAD #100 8700 CAMERON ROAD #100 AUSTIN TX 78754 US 78754


Patients

Patient NumberTreatmentOutcomeDate
10 2019-05-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.